Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Mandibular Neoplasms × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2782 Carcinoma, Non-Small-Cell Lung 2333 Breast Neoplasms 2198 Colorectal Neoplasms 1230 Prostatic Neoplasms 1126 Neoplasm Metastasis 1118 Multiple Myeloma 952 Melanoma 944 Ovarian Neoplasms 859 Recurrence 797 Lung Neoplasms 789 Leukemia, Myeloid, Acute 765 Pancreatic Neoplasms 708 Lymphoma, Non-Hodgkin 654 Lymphoma 622 Stomach Neoplasms 585 Carcinoma, Renal Cell 570 Carcinoma, Hepatocellular 551 Leukemia, Lymphocytic, Chronic, B-Cell 488 Squamous Cell Carcinoma of Head and Neck 467 Lymphoma, Follicular 438 Head and Neck Neoplasms 415 Glioblastoma 404 Lymphoma, Large B-Cell, Diffuse 387 Small Cell Lung Carcinoma 372 Leukemia 371 Triple Negative Breast Neoplasms 359 Advanced Solid Tumors 358 Urinary Bladder Neoplasms 356 Uterine Cervical Neoplasms 354

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03678467 2022-05-27

EB-CMF

Epibone, Inc.

Phase 1/2 Unknown

Congenital Abnormalities, Mandibular Injuries, Mandibular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡